{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T10:41:42Z","timestamp":1770460902866,"version":"3.49.0"},"reference-count":65,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000},"content-version":"unspecified","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,2,23]]},"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Targeted, tailored interventions to test high-risk individuals for HIV and hepatitis C virus (HCV) are vital to achieving HIV control and HCV microelimination in Africa. Compared with the general population, people who inject drugs (PWID) are at increased risk of HIV and HCV and are less likely to be tested or successfully treated. Assisted partner services (APS) increases HIV testing among partners of people living with HIV and improves case finding and linkage to care. We describe a study in Kenya examining whether APS can be adapted to find, test and link to HIV care the partners of HIV-positive PWID using a network of community-embedded peer educators (PEs). Our study also identifies HCV-positive partners and uses phylogenetic analysis to determine risk factors for onward transmission of both viruses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective cohort study leverages a network of PEs to identify 1000 HIV-positive PWID for enrolment as index participants. Each index completes a questionnaire and provides names and contact information of all sexual and injecting partners during the previous 3 years. PEs then use a stepwise locator protocol to engage partners in the community and bring them to study sites for enrolment, questionnaire completion and rapid HIV and HCV testing. Outcomes include number and type of partners per index who are mentioned, enrolled, tested, diagnosed with HIV and HCV and linked to care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Potential index participants are screened for intimate partner violence (IPV) and those at high risk are not eligible to enrol. Those at medium risk are monitored for IPV following enrolment. A community advisory board engages in feedback and discussion between the community and the research team. A safety monitoring board discusses study progress and reviews data, including IPV monitoring data. Dissemination plans include presentations at quarterly Ministry of Health meetings, local and international conferences and publications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" specific-use=\"clinicaltrial pre-results\" xlink:href=\"NCT03447210\">NCT03447210<\/jats:ext-link>\n                      , Pre-results stage.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2020-041083","type":"journal-article","created":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T07:20:13Z","timestamp":1619248813000},"page":"e041083","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["Peer-mediated HIV assisted partner services to identify and link to care HIV-positive and HCV-positive people who inject drugs: a cohort study protocol"],"prefix":"10.1136","volume":"11","clinical-trial-number":[{"clinical-trial-number":"nct03447210","registry":"10.18810\/clinical-trials-gov","type":"preResults"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8843-3462","authenticated-orcid":false,"given":"Aliza","family":"Monroe-Wise","sequence":"first","affiliation":[{"name":"Department of Global Health, University of Washington, Seattle, Washington, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loice","family":"Mbogo","sequence":"additional","affiliation":[{"name":"HIV Testing and Counseling and HIV Prevention, Kenyatta National Hospital, Nairobi, Kenya"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2059-3291","authenticated-orcid":false,"given":"Brandon","family":"Guthrie","sequence":"additional","affiliation":[{"name":"Department of Global Health, University of Washington, Seattle, Washington, USA"},{"name":"Department of Epidemiology, University of Washington, Seattle, Washington, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Bukusi","sequence":"additional","affiliation":[{"name":"HIV Testing and Counseling and HIV Prevention, Kenyatta National Hospital, Nairobi, Kenya"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betsy","family":"Sambai","sequence":"additional","affiliation":[{"name":"HIV Testing and Counseling and HIV Prevention, Kenyatta National Hospital, Nairobi, Kenya"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhavna","family":"Chohan","sequence":"additional","affiliation":[{"name":"Department of Global Health, University of Washington, Seattle, Washington, USA"},{"name":"Kenya Medical Research Institute, Nairobi, Kenya"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Scott","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Washington, Seattle, Washington, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Cherutich","sequence":"additional","affiliation":[{"name":"Kenya\u2019s Ministry of Health, Nairobi, Kenya"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helgar","family":"Musyoki","sequence":"additional","affiliation":[{"name":"Kenya\u2019s Ministry of Health, Nairobi, Kenya"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rose","family":"Bosire","sequence":"additional","affiliation":[{"name":"Kenya Medical Research Institute, Nairobi, Kenya"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Dunbar","sequence":"additional","affiliation":[{"name":"Center for Studies in Demography and Ecology, University of Washinigton, Seattle, Washington, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Macharia","sequence":"additional","affiliation":[{"name":"Kenya\u2019s Ministry of Health, Nairobi, Kenya"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Masyuko","sequence":"additional","affiliation":[{"name":"Department of Global Health, University of Washington, Seattle, Washington, USA"},{"name":"Kenya\u2019s Ministry of Health, Nairobi, Kenya"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduan","family":"Wilkinson","sequence":"additional","affiliation":[{"name":"KwaZulu-Natal Research and Innovation Sequencing Platform, University of KwaZulu-Natal, Durban, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tulio","family":"De Oliveira","sequence":"additional","affiliation":[{"name":"KwaZulu-Natal Research and Innovation Sequencing Platform, University of KwaZulu-Natal, Durban, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Ludwig-Barron","sequence":"additional","affiliation":[{"name":"Department of Global Health, University of Washington, Seattle, Washington, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bill","family":"Sinkele","sequence":"additional","affiliation":[{"name":"Support for Addiction Prevention and Treatment in Africa, Nairobi, Kenya"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Herbeck","sequence":"additional","affiliation":[{"name":"Department of Global Health, University of Washington, Seattle, Washington, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carey","family":"Farquhar","sequence":"additional","affiliation":[{"name":"Department of Global Health, University of Washington, Seattle, Washington, USA"},{"name":"Department of Epidemiology, University of Washington, Seattle, Washington, USA"},{"name":"Department of Medicine, University of Washington, Seattle, Washington, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,4,24]]},"reference":[{"key":"2025121409505217000_11.4.e041083.1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2015-000010"},{"key":"2025121409505217000_11.4.e041083.2","unstructured":"UNAIDS . 90-90-90: an ambitious treatment target to help end the AIDS epidemic, 2014. Available: http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/90-90-90_en.pdf"},{"key":"2025121409505217000_11.4.e041083.3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186316","article-title":"Reaching the \"first 90\": Gaps in coverage of HIV testing among people living with HIV in 16 African countries","volume":"12","author":"Staveteig","year":"2017","journal-title":"PLoS One"},{"key":"2025121409505217000_11.4.e041083.4","unstructured":"National AIDS and STI Control Programme (NASCOP) . Preliminary KENPHIA 2018 report, 2020. Available: https:\/\/phia.icap.columbia.edu\/wp-content\/uploads\/2020\/04\/KENPHIA-2018_Preliminary-Report_final-web.pdf"},{"key":"2025121409505217000_11.4.e041083.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2011.05.030"},{"key":"2025121409505217000_11.4.e041083.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61311-2"},{"key":"2025121409505217000_11.4.e041083.7","unstructured":"National AIDS Control Council, National AIDS and STI Control Programme , 2014. Available: https:\/\/hivpreventioncoalition.unaids.org\/country-action\/kenya-hiv-prevention-revolution-road-map-june-2014\/ [Accessed 08\/03\/2021]."},{"key":"2025121409505217000_11.4.e041083.8","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/QAI.0000000000000769","article-title":"Hiv prevalence, estimated incidence, and risk behaviors among people who inject drugs in Kenya","volume":"70","author":"Kurth","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025121409505217000_11.4.e041083.9","unstructured":"Ndetei DM . A sudy on the linkages between drug abuse, injecting drug use and HIV\/AIDS in Kenya: a rapid situation assessment.. Nairobi University of Nairobi; 2004. http:\/\/erepository.uonbi.ac.ke\/handle\/11295\/65170?show=full [Accessed 08\/03\/21]."},{"key":"2025121409505217000_11.4.e041083.10","unstructured":"Odek-Ogunde M , Okoth F , Lore W , et al . Seroprevalence of HIV, HbC and HCV in injecting drug users in Nairobi, Kenya: World Health organization drug injecting study phase II findings. The XV International AIDS Converence; 2004, Bangkok, Thailand, 2004."},{"key":"2025121409505217000_11.4.e041083.11","unstructured":"National AIDS Control Council . Kenya HIV estimates report, 2018. Available: https:\/\/nacc.or.ke\/wp-content\/uploads\/2018\/11\/HIV-estimates-report-Kenya-20182.pdf"},{"key":"2025121409505217000_11.4.e041083.12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10461-014-0936-3","article-title":"Hiv and STI prevalence and injection behaviors among people who inject drugs in Nairobi: results from a 2011 bio-behavioral study using respondent-driven sampling","volume":"19 Suppl 1","author":"Tun","year":"2015","journal-title":"AIDS Behav"},{"key":"2025121409505217000_11.4.e041083.13","unstructured":"Lizcano J . Testing and linkage to care for injecting drug users. 11th International Conference on HIV Treatment and Prevention Adherence; 2016, Fort Lauderdale, FL, 2016."},{"key":"2025121409505217000_11.4.e041083.14","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1097\/QAI.0000000000000137","article-title":"Populations at increased risk for HIV infection in Kenya: results from a national population-based household survey, 2012","volume":"66 Suppl 1","author":"Githuka","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025121409505217000_11.4.e041083.15","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S1473-3099(19)30264-6","article-title":"Prevalence, estimated incidence, risk behaviours, and genotypic distribution of hepatitis C virus among people who inject drugs accessing harm-reduction services in Kenya: a retrospective cohort study","volume":"19","author":"Akiyama","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2025121409505217000_11.4.e041083.16","doi-asserted-by":"crossref","DOI":"10.4314\/eamj.v85i7.9649","article-title":"Prevalence of hepatitis C virus and its genotypes among a cohort of drug users in Kenya","volume":"85","author":"Muasya","year":"2008","journal-title":"East Afr Med J"},{"key":"2025121409505217000_11.4.e041083.17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.11604\/pamj.2019.34.31.17885","article-title":"Prevalence and associated risk factors of transfusion transmissible infections among blood donors at regional blood transfusion center Nakuru and Tenwek mission Hospital, Kenya","volume":"34","author":"Bartonjo","year":"2019","journal-title":"Pan Afr Med J"},{"key":"2025121409505217000_11.4.e041083.18","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/QAD.0000000000002070","article-title":"Extremely low hepatitis C prevalence among HIV co-infected individuals in four countries in sub-Saharan Africa","volume":"33","author":"Loarec","year":"2019","journal-title":"AIDS"},{"key":"2025121409505217000_11.4.e041083.19","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2019.105859","article-title":"Rationale and design of a randomized pragmatic trial of patient-centered models of hepatitis C treatment for people who inject drugs: the hero study","volume":"87","author":"Litwin","year":"2019","journal-title":"Contemp Clin Trials"},{"key":"2025121409505217000_11.4.e041083.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1465-3362.2012.00468.x"},{"key":"2025121409505217000_11.4.e041083.21","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-019-0338-y","article-title":"High prevalence of hepatitis C virus infection and low level of awareness among people who recently started injecting drugs in a cross-sectional study in Germany, 2011-2014: missed opportunities for hepatitis C testing","volume":"17","author":"Enkelmann","year":"2020","journal-title":"Harm Reduct J"},{"key":"2025121409505217000_11.4.e041083.22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/liv.13949","article-title":"Hepatitis C elimination among people who inject drugs: challenges and recommendations for action within a health systems framework","volume":"39","author":"Day","year":"2019","journal-title":"Liver Int"},{"key":"2025121409505217000_11.4.e041083.23","unstructured":"Medicins du Monde . Our activities in Kenya, 2020. Available: https:\/\/www.medecinsdumonde.org\/en\/countries\/africa\/kenya"},{"key":"2025121409505217000_11.4.e041083.24","unstructured":"Cherutich P , Kurth A , Lizcano JA . Integration of hepatitis C treatment services with harm reduction service centers for people who inject drugs in Kenya: experience from test and link to care for injecting drug users study. International Viral Hepatitis Elimiation Meeting, Amsterdam, The Netherlands, 2019."},{"key":"2025121409505217000_11.4.e041083.25","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001555"},{"key":"2025121409505217000_11.4.e041083.26","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-017-1750-5"},{"key":"2025121409505217000_11.4.e041083.27","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1016\/S2352-3018(16)30214-4","article-title":"Assisted partner services for HIV in Kenya: a cluster randomised controlled trial","volume":"4","author":"Cherutich","year":"2017","journal-title":"Lancet HIV"},{"key":"2025121409505217000_11.4.e041083.28","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-017-1936-x"},{"key":"2025121409505217000_11.4.e041083.29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/QAD.0000000000001697","article-title":"Assisted partner notification services are cost-effective for decreasing HIV burden in Western Kenya","volume":"32","author":"Sharma","year":"2018","journal-title":"AIDS"},{"key":"2025121409505217000_11.4.e041083.30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199201093260205"},{"key":"2025121409505217000_11.4.e041083.31","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000000529"},{"key":"2025121409505217000_11.4.e041083.32","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e318202bf7d"},{"key":"2025121409505217000_11.4.e041083.33","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-011-0094-9"},{"key":"2025121409505217000_11.4.e041083.34","unstructured":"World Health Organization . WHO recommends assistance for people with HIV to notify their partners, 2019. Available: http:\/\/www.who.int\/hiv\/pub\/vct\/who-partner-notification-policy\/en\/"},{"key":"2025121409505217000_11.4.e041083.35","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1007\/s10461-018-2035-3","article-title":"Hiv partner notification values and preferences among sex workers, fishermen, and mainland community members in Rakai, Uganda: a qualitative study","volume":"22","author":"Quinn","year":"2018","journal-title":"AIDS Behav"},{"key":"2025121409505217000_11.4.e041083.36","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/OLQ.0000000000000449","article-title":"Opt-Out referral of men who have sex with men newly diagnosed with HIV to partner notification officers: results and yield of sexual partners being contacted","volume":"43","author":"Rane","year":"2016","journal-title":"Sex Transm Dis"},{"key":"2025121409505217000_11.4.e041083.37","doi-asserted-by":"publisher","DOI":"10.1007\/s12160-011-9299-4"},{"key":"2025121409505217000_11.4.e041083.38","first-page":"160","article-title":"The outreach-assisted model of partner notification with IDUs","volume":"113 Suppl 1","author":"Levy","year":"1998","journal-title":"Public Health Rep"},{"key":"2025121409505217000_11.4.e041083.39","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25317","article-title":"Integrating assisted partner notification within HIV prevention service package for people who inject drugs in Pakistan","volume":"22 Suppl 3","author":"Malik","year":"2019","journal-title":"J Int AIDS Soc"},{"key":"2025121409505217000_11.4.e041083.40","doi-asserted-by":"crossref","first-page":"e357","DOI":"10.1016\/S2352-3018(17)30073-5","article-title":"Hiv and the criminalisation of drug use among people who inject drugs: a systematic review","volume":"4","author":"DeBeck","year":"2017","journal-title":"Lancet HIV"},{"key":"2025121409505217000_11.4.e041083.41","unstructured":"United Nations, Office on Drugs and Crime . World drug report 2016. Geneva United Nations Office on Drugs and Crime (UNODC); 2016."},{"key":"2025121409505217000_11.4.e041083.42","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/dar.12978","article-title":"Barriers to effective management of hepatitis C virus in people who inject drugs: evidence from outpatient clinics","volume":"38","author":"Molinaro","year":"2019","journal-title":"Drug Alcohol Rev"},{"key":"2025121409505217000_11.4.e041083.43","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3109\/16066359.2015.1068301","article-title":"Barriers to practicing risk reduction strategies among people who inject drugs","volume":"24","author":"Phillips","year":"2016","journal-title":"Addict Res Theory"},{"key":"2025121409505217000_11.4.e041083.44","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/fdv143"},{"key":"2025121409505217000_11.4.e041083.45","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu563"},{"key":"2025121409505217000_11.4.e041083.46","doi-asserted-by":"crossref","first-page":"S248","DOI":"10.1097\/QAI.0b013e3182986f96","article-title":"Future of phylogeny in HIV prevention","volume":"63 Suppl 2","author":"Brenner","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025121409505217000_11.4.e041083.47","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27310"},{"key":"2025121409505217000_11.4.e041083.48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001610"},{"key":"2025121409505217000_11.4.e041083.49","doi-asserted-by":"publisher","DOI":"10.1038\/nature07390"},{"key":"2025121409505217000_11.4.e041083.50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009311","article-title":"The HIV-1 subtype C epidemic in South America is linked to the United Kingdom","volume":"5","author":"de Oliveira","year":"2010","journal-title":"PLoS One"},{"key":"2025121409505217000_11.4.e041083.51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000590"},{"key":"2025121409505217000_11.4.e041083.52","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/01.aids.0000161778.15568.a1","article-title":"Investigation of HIV-1 transmission events by phylogenetic methods: requirement for scientific rigour","volume":"19","author":"Hu\u00e9","year":"2005","journal-title":"AIDS"},{"key":"2025121409505217000_11.4.e041083.53","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1097\/QAD.0b013e3283573244","article-title":"Phylogenetic insights into regional HIV transmission","volume":"26","author":"Dennis","year":"2012","journal-title":"AIDS"},{"key":"2025121409505217000_11.4.e041083.54","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32835805b6"},{"key":"2025121409505217000_11.4.e041083.55","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyt276"},{"key":"2025121409505217000_11.4.e041083.56","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32833ac9e6"},{"key":"2025121409505217000_11.4.e041083.57","doi-asserted-by":"publisher","DOI":"10.1086\/512088"},{"key":"2025121409505217000_11.4.e041083.58","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/aid.2010.0115","article-title":"Hiv transmission patterns among the Netherlands, Suriname, and the Netherlands Antilles: a molecular epidemiological study","volume":"27","author":"Kramer","year":"2011","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2025121409505217000_11.4.e041083.59","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/OLQ.0000000000000032","article-title":"Scale-Up and case-finding effectiveness of an HIV partner services program in Cameroon: an innovative HIV prevention intervention for developing countries","volume":"40","author":"Henley","year":"2013","journal-title":"Sex Transm Dis"},{"key":"2025121409505217000_11.4.e041083.60","unstructured":"Centers for Disease Control and Prevention (CDC) 410572008-001. Intimate partner violence and sexual violence victimization assessment instruments for use in healthcare settings Centers for Disease Control and Prevention (CDC); 2007."},{"key":"2025121409505217000_11.4.e041083.61","doi-asserted-by":"crossref","unstructured":"Monroe\u2010Wise A , Maingi Mutiti P , Kimani H , et al . Assisted partner notification services for patients receiving HIV care and treatment in an HIV clinic in Nairobi, Kenya: a qualitative assessment of barriers and opportunities for scale\u2010up. J Int AIDS Soc 2019;22.doi:10.1002\/jia2.25315","DOI":"10.1002\/jia2.25315"},{"key":"2025121409505217000_11.4.e041083.62","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001638"},{"key":"2025121409505217000_11.4.e041083.63","unstructured":"KELIN and the Kenya Key Populations Consortium . \u201cEveryone said no:\u201d biometrics, HIV and human rights \u2013 A Kenya case study. KELIN, 2018. Available: https:\/\/www.kelinkenya.org\/everyonesaidno\/"},{"key":"2025121409505217000_11.4.e041083.64","unstructured":"Gathura G . Biometrics system for identifying people living with HIV ready. The standard, 2019. Available: https:\/\/www.standardmedia.co.ke\/article\/2001349675\/biometrics-system-for-identifying-people-living-with-hiv-ready"},{"key":"2025121409505217000_11.4.e041083.65","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmedinf.2019.104006","article-title":"Feasibility and acceptability of an iris biometric system for unique patient identification in routine HIV services in Kenya","volume":"133","author":"Anne","year":"2020","journal-title":"Int J Med Inform"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-041083","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T17:51:05Z","timestamp":1765734665000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-041083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":65,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,24]]},"published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1136\/bmjopen-2020-041083"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-041083","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}